Mc Donald JW, Althomsons SP, Hyrc KL, et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainite receptor-me-diated excitotoxity[J]. Nat Med, 1998,4(3):291-297.
[3]
Cavallini A, MicieliG, MarcheselliS, et al. Role of monitoring in management of acute ischemic stroke patients[J]. Stroke,2003,34(11): 2599-2603.
[4]
Li PA, He QP, Yi-Bing, et al. Phosphorylation of extracellular signal-regulated kinase after transient cerebral ischemia in hyperglycemic rats [J]. Neurobiol Dis, 2001,8(1): 127-35.
Murray B, Alessandrini A, Cole AJ. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity[J]. Proc Natl Acad Sci USA,1998,95:11975-11980.
[7]
Hu BR, Liu CL, Park DL. Alteration of MAP kinase pathways after transient forebrain ischemia[J]. Cereb Blood Flow Metab, 2000,20(7):1089-1095.
[8]
Namura S, Iihara K, Takama S, et al. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebain ischemia and focal cerebal ischemia[J]. Proc Natl Acad Sci USA, 2001,98:11569-11574.
